IFP Advisors’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $554K | Buy |
5,022
+1,083
| +27% | +$105K | 0.01% | 1009 |
|
|
2026
Q2 | $308K | Buy |
3,939
+324
| +9% | +$22.1K | 0.01% | 1275 |
|
|
2026
Q1 | $234K | Sell |
3,615
-31
| -0.9% | -$2.18K | ﹤0.01% | 1306 |
|
|
2025
Q4 | $245K | Sell |
3,646
-1,560
| -30% | -$105K | 0.01% | 1262 |
|
|
2025
Q3 | $382K | Buy |
5,206
+785
| +18% | +$52.1K | 0.01% | 964 |
|
|
2025
Q2 | $233K | Buy |
4,421
+2,318
| +110% | +$132K | 0.01% | 1195 |
|
|
2025
Q1 | $134K | Buy |
2,103
+2,018
| +2,374% | +$117K | ﹤0.01% | 1365 |
|
|
2024
Q4 | $4.06K | Buy |
+85
| New | +$4.36K | ﹤0.01% | 2870 |
|
|
2024
Q3 | – | Sell |
-2,027
| Closed | -$106K | – | 3365 |
|
|
2024
Q2 | $106K | Buy |
2,027
+2,000
| +7,407% | +$87.7K | ﹤0.01% | 1342 |
|
|
2024
Q1 | $1.1K | Buy |
+27
| New | +$1.01K | ﹤0.01% | 2846 |
|
|
2023
Q3 | – | Sell |
-23
| Closed | -$830 | – | 3414 |
|
|
2023
Q2 | $830 | Sell |
23
-502
| -96% | -$17.1K | ﹤0.01% | 3119 |
|
|
2023
Q1 | $9.8K | Buy |
525
+21
| +4% | +$985 | ﹤0.01% | 2297 |
|
|
2022
Q4 | $13K | Sell |
504
-1,213
| -71% | -$62.1K | ﹤0.01% | 3208 |
|
|
2022
Q3 | $38K | Buy |
1,717
+803
| +88% | +$35.5K | ﹤0.01% | 2580 |
|
|
2022
Q2 | $18K | Hold |
914
| – | – | ﹤0.01% | 2939 |
|
|
2022
Q1 | $18K | Buy |
914
+886
| +3,164% | +$31.6K | ﹤0.01% | 2938 |
|
|
2021
Q4 | $1K | Sell |
28
-1,837
| -98% | -$68.6K | ﹤0.01% | 3015 |
|
|
2021
Q3 | $78K | Sell |
1,865
-57
| -3% | -$2.38K | ﹤0.01% | 1400 |
|
|
2021
Q2 | $88K | Sell |
1,922
-1,020
| -35% | -$45.1K | ﹤0.01% | 1297 |
|
|
2021
Q1 | $123K | Buy |
2,942
+618
| +27% | +$28.2K | ﹤0.01% | 1075 |
|
|
2020
Q4 | $100K | Buy |
+2,324
| New | +$83.5K | ﹤0.01% | 1138 |
|
|
2019
Q1 | – | Sell |
-9,225
| Closed | -$132K | – | 2786 |
|
|
2018
Q4 | $132K | Sell |
9,225
-2,075
| -18% | -$33.1K | 0.01% | 1054 |
|
|
2018
Q3 | $205K | Buy |
11,300
+225
| +2% | +$3.94K | 0.01% | 1063 |
|
|
2018
Q2 | $187K | Sell |
11,075
-2,300
| -17% | -$43.5K | 0.01% | 1093 |
|
|
2018
Q1 | $271K | Hold |
13,375
| – | – | 0.01% | 863 |
|
|
2017
Q4 | $271K | Buy |
13,375
+1,739
| +15% | +$32K | 0.01% | 865 |
|
|
2017
Q3 | $202K | Sell |
11,636
-3,050
| -21% | -$41.3K | 0.01% | 1133 |
|
|
2017
Q2 | $188K | Buy |
14,686
+1,226
| +9% | +$16.4K | 0.01% | 1159 |
|
|
2017
Q1 | $174K | Buy |
13,460
+2,850
| +27% | +$36K | 0.01% | 1191 |
|
|
2016
Q4 | $105K | Buy |
10,610
+1,499
| +16% | +$16.4K | 0.01% | 1420 |
|
|
2016
Q3 | $110K | Sell |
9,111
-1,966
| -18% | -$20.1K | 0.01% | 1307 |
|
|
2016
Q2 | $96K | Buy |
+11,077
| New | +$109K | 0.01% | 1364 |
|
|
2016
Q1 | – | Sell |
-2,836
| Closed | -$49K | – | 2805 |
|
|
2015
Q4 | $49K | Buy |
+2,836
| New | +$45.2K | ﹤0.01% | 1639 |
|
Other funds holding HALO
IFP Advisors's HALO Position: Q3 2026 in Review
IFP Advisors increased its Halozyme (HALO) stake by 27% in Q3 2026, buying an estimated $105K and bringing the position to 5,022 shares worth $554K. The position accounts for 0.01% of the portfolio, ranked #1009.
IFP Advisors first reported a position in HALO in Q4 2015 and has held it in 33 quarters since. 412 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- IFP Advisors held 5,022 shares of Halozyme worth $554K as of Q3 2026.
- IFP Advisors bought 1,083 Halozyme shares in Q3 2026, an estimated $105K.
- Halozyme made up 0.01% of IFP Advisors's portfolio in Q3 2026, its #1009 holding.
- IFP Advisors first reported a position in Halozyme in Q4 2015 and has held it in 33 quarters since.
- 412 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.